Randomized phase III trial of tamoxifen versus thalidomide in women with biochemical-recurrent-only epithelial ovarian, fallopian tube or primary peritoneal carcinoma after a complete response to first-line platinum/taxane chemotherapy with an evaluation of serum vascular endothelial growth factor (VEGF): A Gynecologic Oncology Group Study

✍ Scribed by Jean A. Hurteau; Mark F. Brady; Kathleen M. Darcy; William P. McGuire; Pamela Edmonds; Michael L. Pearl; Iouri Ivanov; Krishnansu S. Tewari; Robert S. Mannel; Kristine Zanotti; Doris M. Benbrook

• Book ID: 113962589
• Publisher: Elsevier Science
• Year: 2010
• Tongue: English
• Weight: 490 KB
• Volume: 119
• Category: Article
• ISSN: 0090-8258
• DOI: 10.1016/j.ygyno.2010.08.002